Journal
CANCER INVESTIGATION
Volume 36, Issue 2, Pages 118-128Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2018.1430816
Keywords
Antibodies; radiolabeling; PSMA; prostate cancer
Categories
Ask authors/readers for more resources
Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can carry the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available